FDA approves updated Covid vaccines; Acelyrin, a rare IPO success, stumbles in its first big test

Taking stock of the drug industry, from the lab to the medicine chest

September 11, 2023 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Justin Sullivan/Getty Images FDA approves updated Covid vaccines The move triggers a process that could see the Moderna and Pfizer-BioNTech vaccines become available later this week. By Helen Branswell and Matthew Herper STAT+ | Acelyrin, a rare IPO success, stumbles in its first big test The company's medicine, a subcutaneous treatment called izokibep, is meant to clear up lesions for patients with a common skin disease. By Damian Garde STAT+ | Crinetics acromegaly drug succeeds in late-stage trial but would face stiff competition if approved If approved, the oral Crinetics drug would have to compete against injections sold by Novartis and Ipsen, as well as other therapies. By Jonathan Wosen J. Scott Applewhite/AP STAT+ | House transparency, PBM reform bill gains bipartisan support Rep. Frank Pallone (D-N.J.) signed on to a package that would enact modest payment reforms to PBMs and hospitals. By Rachel Cohrs

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser